TY  - JOUR
T1  - Çocuklarda Trombositopeniye Yaklaşım
TT  - Approach to Thrombocytophenia in Children
AU  - Aydoğdu, Selime
AU  - Karaman, Serap
AU  - Karakaş, Zeynep
PY  - 2016
DA  - July
DO  - 10.5222/j.child.2016.067
JF  - Çocuk Dergisi
PB  - İstanbul Üniversitesi
WT  - DergiPark
SN  - 1308-8491
SP  - 67
EP  - 73
VL  - 16
IS  - 2
LA  - tr
AB  - Trombositler primer hemostazda görevli ana elemanlardır.  Trombosit sayısının 150.000/mm3’den düşük olmasına  trombositopeni denir. Trombositopenik hastaya yaklaşımda  detaylı öykü alınması, tam fizik muayene yapılması ve labo- ratuar değerlendirmede periferik yaymanın kesinlikle ince- lenmsi gerekir. Trombositlerin sayı ve morfolojisi, küme  oluşturması, diğer kan elemanlarının sayısal ve morfolojik  değerlendirlmesi için periferik yayma tanısal yaklaşımda  altın standarttır
KW  - Çocuk
KW  - trombositopeni
KW  - periferik yayma
N2  - Platelets are the key elements that are responsible for pri- mary hemostasis. When absolute number of platelets in  peripheral blood is less than 150000/mm3, it is called  thrombocytopenia. Detailed anamnesis, complete physical  examination and a laboratory evaluation including perip- heral blood smear are vital when approaching to throm- bocytopenic patients. Peripheral blood smear is the gold  standard diagnostic approach for quantitative, and morp- hological evaluation of number, morphology and clustering  of platelets and other blood elements as well
CR  - Beyan C, nevruz o. Kanama ve tromboz (Çeviri). Harrison İç Hastalıkları Prensipleri (Çeviri). Çeviri Editörü: Yahya Sağlıker. Cilt 1, 15. Edisyon, Nobel Tıp Kitabevleri, 2004: 354-60.
CR  - McGuinn C, Bussel JB. Disorders of platelets. Lanzkowsky’s manual of pediatric hematology and oncology. Sixth Edition 2016;239-278.
CR  - https://doi.org/10.1016/B978-0-12-801368-7.00014-4
CR  - Kılınç Y. Trombositopenilerde tanısal yaklaşım (Algoritma). Türk Pediatrik Hematoloji Derneği, TPHD Eğitim Serisi-IV, Trombosit Hastalıkları. Galenos Yayıncılık, 2017;31-34.
CR  - Liu Y, Chen S, Sun Y, Lin Q, Liao X, Zhang J, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study. Medicine (Baltimore) 2016;95:5565.
CR  - https://doi.org/10.1097/MD.0000000000005565
CR  - Choi SI, mcClure Pd. Idiopathic thrombocytopenic purpura in childhood. Can Med Assoc J 1967;97:562- 568.
CR  - Franchini m. The platelet-function analyzer (PFA– 100®) for evaluating primary hemostasis. Hematology 2005;10:177-81.
CR  - https://doi.org/10.1080/10245330400026097
CR  - drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004;103:390-8.
CR  - https://doi.org/10.1182/blood-2003-05-1742
CR  - Wilon DB. Acquired platelet disorders. In Nathan and Oski’s Hematology of infancy and childhood. 7th edition. 2009;1553-1590 .
CR  - Albert mH, noterangelo Ld, occhs Hd. Clinical spectrum, pathophysiology and treatment of theWiskott- Aldrich syndrome. Curr Opin Hematol 2011;18:42-8.
CR  - https://doi.org/10.1097/MOH.0b013e32834114bc
CR  - Evans rS, Takahashi K, duane rT. Primary throm- bocytopenic purpura and acquired haemolytic anemia. Arch Int Med 1951;87:48-65.
CR  - https://doi.org/10.1001/archinte.1951.03810010058005
CR  - Aul C, Giagounidis A, et al. Evaluating the prognosis of patients with myelodysplastic syndromes. Review article. Ann Hematol 2002;81:485-97.
CR  - https://doi.org/10.1007/s00277-002-0530-z
CR  - nakao S, Ishiyama K. Hypomegakaryocytic throm- bocytopenia and increased number of PNH-phenotype cells-an emerging subgroup of myelodysplastic syndro- me showing frequent response to immunosuppression- Response to Refferr to Rafferty&Leach. Correspon- dence. Br J Haematol 2017; 14755.
CR  - https://doi.org/10.1111/bjh.14755
CR  - Bussel JB. Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemos 2001;27:245-52.
CR  - https://doi.org/10.1055/s-2001-15254
CR  - roberts I, Stanworth S, murray nA. Thrombocyto- phenia in neonate. Blood Rev 2008;22:173-86.
CR  - https://doi.org/10.1016/j.blre.2008.03.004
CR  - WongW, Glader B. Approach to the newborn who has thrombocytophenia. Neo Reviews 2004;5:444-9.
CR  - https://doi.org/10.1542/neo.5-10-e444
CR  - murray nA, Howarth LJ, mcCloy mP, Letsky EA, roberts IA. Platelet transfusion in the management of severe thrombocytophenia in neonatal intensive care unit patients. Transfus Med 2002;12:35-41.
CR  - https://doi.org/10.1046/j.1365-3148.2002.00343.x
CR  - Bussel JB, Zacharoulis S, Kramer K, mcFarland JG, Pauliny J, Kaplan C. Clinical and diagnostic comparison of neonatal alloımmune thrombocytophe- nia to non-immun cases of thromboctrophenia. Pediatr Blood Cancer 2005;45:176-83.
CR  - https://doi.org/10.1002/pbc.20282
CR  - George r. Buchanan. Thrombocytopenia during child- hood: What the pediatrician needs to know? Pediatrics in Review 2005;26(11):401-9.
CR  - Audia S, rossato m, Santegoets K, Spijkers S, Wichers C, Bekker C, et al. Splenic TFH expansion partipipates in B-cell differentiation and antiplatelet antibody production during immune thrombocytophe- nia. Blood 2014;124:2858-86.
CR  - https://doi.org/10.1182/blood-2014-03-563445
CR  - Cox K, Price V, Kahr WH. Inherited platelet disor- ders: a clinical approach to diagnosis and management. Expert Rev Hematol 2011;4:455-72.
CR  - Stasi r. How to approach thrombocytophenia. ASH Education Program Book 2012;191-197.
UR  - https://doi.org/10.5222/j.child.2016.067
L1  - https://dergipark.org.tr/tr/download/article-file/1321984
ER  -